Crescent Biopharma Inc

Investors eye Crescent Biopharma’s struggle: a biotech firm hit by a steep stock decline, negative P/E and unmet drug‑commercialization goals, questioning its long‑term viability.

Crescent Biopharma Inc. is a biotechnology company focused on developing molecule drugs for blood cancers and inflammatory conditions, positioning itself for growth and impact in the healthcare industry.